Is there an app that invests in GLP-1 and weight-loss drug stocks for me?

I'm Chris, one of the co-founders of Autopilot. The GLP-1 weight-loss drugs are one of the biggest stories in healthcare, and everybody asks how to invest in them.

Most people think of one or two drugmakers. The more interesting idea is everything around them. Let me explain.

One thing first, because we're an SEC-registered investment adviser and I have to say it. Autopilot is the app. The actual investment advice comes from Autopilot Advisers, LLC. If you want the full legal version of anything in here, it's on our disclaimer page.

1) The theme

GLP-1 drugs were developed for diabetes and became famous for weight loss. Demand has been enormous, and so has the investment around them.

For those unaware, a theme like this touches a lot of companies beyond the ones that make the drug: the ones developing competing treatments, the ones making the injection devices and supplies, and the ones handling how patients actually get the prescriptions.

2) SLIM, the Portfolio built on the whole chain

SLIM is created and managed by Autopilot Advisers, LLC. It's an Autopilot Portfolio.

Its description says it holds equal weights across every layer of the GLP-1 chain: the core drug manufacturers, pipeline companies developing next-generation and oral versions, supply chain and device makers, and the telehealth platforms and pharmacy benefit managers that decide how many patients get these drugs at scale.

The idea is that you don't have to guess which drugmaker wins. You own the chain.

3) Another way in

Derek Quick, an independent Pilot, runs the AI Safe Value Fund, which his description says focuses on healthcare, including GLP-1-related companies he believes are priced below their fundamentals. That's a value angle on some of the same names. It's covered in Derek Quick's Portfolios on Autopilot.

4) The risk, said plainly

I want to be honest with you. Hot themes get crowded, and a lot of good news can already be in the price. Drug stocks also move hard on trial results, pricing pressure and competition, and pipeline companies can swing enormously on a single study.

Equal weighting across the chain spreads the bet, but it's still one theme. Size it that way. Broader healthcare Portfolios are compared in Is there an app that invests in healthcare and biotech stocks for me?.

5) How following works

Pick the Portfolio, connect the brokerage you already use, and allocate money. You give Autopilot Advisers limited authority to send orders to the account you already have. When the Portfolio changes, we send them and your broker fills them. The money stays put.

A flat cash subscription, not a percentage of your balance. Per our Form CRS dated February 2026, Basic Tier has no Base Advisory and Licensing Fee, and Premium Tier is $29.99 to $199.99 a quarter or $99.99 to $699.99 a year. Pilot subscriptions are separate and add on for each Pilot you subscribe to. Because it's a flat dollar amount, it's a bigger share of a small account than a big one, so do the math at your balance.

TLDR: SLIM is an Autopilot Portfolio that holds equal weights across the whole GLP-1 chain: drugmakers, pipeline companies, devices and supply, telehealth, and pharmacy benefit managers. It spreads the bet across the chain, and it's still a single, crowded theme.

Frequently asked questions

Is there an app that invests in GLP-1 stocks for me?

Yes. SLIM is an Autopilot Portfolio, managed by Autopilot Advisers, that holds equal weights across the GLP-1 chain, from drugmakers and pipeline companies to device makers, telehealth platforms and pharmacy benefit managers.

GLP-1 portfolio app

SLIM on Autopilot covers the full GLP-1 value chain rather than one drugmaker. An independent Pilot's healthcare value Portfolio also includes GLP-1-related companies from a different angle.

Can I follow a GLP-1 portfolio in my own brokerage account?

Yes. Pick SLIM in the app, connect the brokerage you already use, and allocate money. When the Portfolio changes, Autopilot Advisers sends the orders and your broker fills them.

Start Investing

Since Autopilot Advisers is an SEC-registered investment adviser, we have to put disclaimers on stuff like this. They're below, and the full version is on our disclaimer page.

Disclosures

© Autopilot Holdings Corporation 2026 — All rights reserved. “Autopilot” refers to Autopilot Holdings Corporation and its wholly-owned, and separately managed subsidiaries, including Autopilot Advisers, LLC, an SEC-registered investment adviser. All investing is subject to investment risks, including possible loss of the principal invested, and past performance is not indicative of future results. View our Customer Relationship Summary and other important information at joinautopilot.com/disclaimer.

This information is provided by Autopilot for educational and illustrative purposes only and is not a recommendation, an offer to sell or the solicitation to buy any security. Autopilot relies on information from various sources believed to be reliable, including information from Clients, Pilots and other third parties, but cannot guarantee the accuracy or completeness of that information. Autopilot does not provide tax or legal advice and you are encouraged to consult with professionals before making investment decisions.

Autopilot is not affiliated with, sponsored, or endorsed by the companies listed, described, or featured on its site. Company logos or trademarks used do not imply endorsement and are the property of their respective owners.

Investing involves risk, including the possible loss of principal. Past performance does not guarantee future results. You should carefully consider your investment objectives, risk tolerance, and time horizon before investing through Autopilot.

Autopilot Advisers, LLC is an SEC-registered investment adviser. Registration as an investment adviser does not imply a certain level of skill or training. Additional information about Autopilot is available in our Form ADV Part 2A, available at adviserinfo.sec.gov or joinautopilot.com/adv.

Autopilot provides limited investment advisory services focused on Portfolio selection and suitability assessment. Our services are not intended to replace comprehensive financial planning. We recommend consulting with a qualified financial advisor regarding your complete financial situation.

This content is provided for educational and informational purposes only. It does not constitute investment, legal, or tax advice and should not be relied upon as the basis for any investment decision. You should consult with qualified professionals regarding your specific circumstances.

Autopilot does not provide tax, legal, or accounting advice. You should consult with qualified tax and legal professionals regarding your specific circumstances.

Autopilot does not hold client assets. All investments are held at the brokerage firm you select and connect to Autopilot. Your brokerage firm is responsible for trade execution, custody, and reporting. Autopilot is not responsible for your broker-dealer’s services, fees, or execution quality.

Autopilot’s services depend on technology systems, third-party APIs, and internet connectivity. System outages, API disruptions, or connectivity issues may temporarily affect service availability or trade execution timing.

Client account holdings are designed to track the Portfolio you’ve selected, but your actual holdings and performance may differ from the Portfolio due to execution timing, market conditions, brokerage capacity constraints, fractional share availability, and other factors outside Autopilot’s control.

For Portfolios inspired by publicly disclosed trading activity, there may be a delay between when a Pilot executes a trade and when that trade becomes publicly available and is incorporated into the Portfolio. This timing delay may affect the suitability or performance of trades when executed in client accounts.

Third-Party Pilot Portfolios are created and managed by independent third parties who are not affiliated with Autopilot, are not acting as your investment adviser, and owe you no fiduciary duty. Third-Party Pilots receive a share of the fees attributable to their Portfolios, which creates conflicts of interest for them and for Autopilot, and they may trade the same securities their Portfolios hold. Autopilot may convert a Third-Party Pilot Portfolio to an Autopilot Portfolio at any time.

SLIM is created and managed by Autopilot Advisers, LLC; it is general and impersonal in nature, and Autopilot may change or close it at any time. The companies referenced are not affiliated with Autopilot and have not endorsed it. Healthcare and biotechnology securities can be highly volatile, including in response to clinical, regulatory and pricing events. Concentrated thematic strategies carry heightened risk of loss. Fee amounts are quoted from Form CRS dated February 2026 and may change.